Nesiritide fails to reduce the mortality of patients with acute decompensated heart failure: An updated systematic review and cumulative meta-analysis

International Journal of Cardiology

Volumn 177, Issue 2, 2014, Pages 505-509

  Yan, Bin ^a   Peng, Liyuan ^a   Zhao, Xiaojing ^a   Chung, Hsingchun ^b   Li, Lijun ^a   Zeng, Lingfang ^c   Ong, Heanyee ^d   Wang, Gang ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b E DA HOSPITAL   (Taiwan)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

Acute decompensated heart failure; Meta analysis; Mortality; Nesiritide; Systematic review

Indexed keywords

BRAIN NATRIURETIC PEPTIDE;

ACUTE DISEASE; HEART FAILURE; HUMAN; META ANALYSIS; MORTALITY; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT FAILURE;

ACUTE DISEASE; HEART FAILURE; HUMANS; NATRIURETIC PEPTIDE, BRAIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT FAILURE;

EID: 84913604139     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2014.08.078     Document Type: Article

References (21)

1. J.J. McMurray, S. Adamopoulos, and S.D. Anker ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC Eur Heart J 33 2012 1787 1847
2. C.M. O'Connor, R.C. Starling, and A.F. Hernandez Effect of nesiritide in patients with acute decompensated heart failure N Engl J Med 365 2011 32 43
3. C.W. Yancy, H. Krum, and B.M. Massie Safety and efficacy of outpatient nesiritide in patients with advanced heart failure: results of the Second Follow-Up Serial Infusions of Nesiritide (FUSION II) trial Circ Heart Fail 1 2008 9 16
4. S.L. Chow, S.A. O'Barr, and J. Peng Renal function and neurohormonal changes following intravenous infusions of nitroglycerin versus nesiritide in patients with acute decompensated heart failure J Card Fail 17 2011 181 187
5. M.A. Silver, D.P. Horton, J.K. Ghali, and U. Elkayam Effect of nesiritide versus dobutamine on short-term outcomes in the treatment of patients with acutely decompensated heart failure J Am Coll Cardiol 39 2002 798 803
6. J.D. Sackner-Bernstein, M. Kowalski, M. Fox, and K. Aaronson Short-term risk of death after treatment with nesiritide for decompensated heart failure: a pooled analysis of randomized controlled trials JAMA 293 2005 1900 1905
7. W.T. Abraham, R.J. Trupp, and D. Jarjoura Nesiritide in acute decompensated heart failure: a pooled analysis of randomized controlled trials Clin Cardiol 33 2010 484 489
8. S.A. Olivo, L.G. Macedo, I.C. Gadotti, J. Fuentes, T. Stanton, and D.J. Magee Scales to assess the quality of randomized controlled trials: a systematic review Phys Ther 88 2008 156 175
9. A.R. Jadad, R.A. Moore, and D. Carroll Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials 17 1996 1 12
10. R.M. Mills, T.H. LeJemtel, and D.P. Horton Sustained hemodynamic effects of an infusion of nesiritide (human b-type natriuretic peptide) in heart failure: a randomized, double-blind, placebo-controlled clinical trial. Natrecor Study Group J Am Coll Cardiol 34 1999 155 162
11. W.S. Colucci, U. Elkayam, and D.P. Horton Intravenous nesiritide, a natriuretic peptide, in the treatment of decompensated congestive heart failure. Nesiritide Study Group N Engl J Med 343 2000 246 253
12. A.J. Burger, U. Elkayam, and M.T. Neibaur Comparison of the occurrence of ventricular arrhythmias in patients with acutely decompensated congestive heart failure receiving dobutamine versus nesiritide therapy Am J Cardiol 88 2001 35 39
13. Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial JAMA 287 2002 1531 1540
14. A.J. Burger, D.P. Horton, and T. LeJemtel Effect of nesiritide (B-type natriuretic peptide) and dobutamine on ventricular arrhythmias in the treatment of patients with acutely decompensated congestive heart failure: the PRECEDENT study Am Heart J 144 2002 1102 1108
15. C.W. Yancy, M.T. Saltzberg, and R.L. Berkowitz Safety and feasibility of using serial infusions of nesiritide for heart failure in an outpatient setting (from the FUSION I trial) Am J Cardiol 94 2004 595 601
16. Peacock WFt, R. Holland, and R. Gyarmathy Observation unit treatment of heart failure with nesiritide: results from the proaction trial J Emerg Med 29 2005 243 252
17. R.M. Witteles, D. Kao, and D. Christopherson Impact of nesiritide on renal function in patients with acute decompensated heart failure and pre-existing renal dysfunction a randomized, double-blind, placebo-controlled clinical trial J Am Coll Cardiol 50 2007 1835 1840
18. A.H. Miller, S. Nazeer, P. Pepe, B. Estes, A. Gorman, and C.W. Yancy Acutely decompensated heart failure in a county emergency department: a double-blind randomized controlled comparison of nesiritide versus placebo treatment Ann Emerg Med 51 2008 571 578
19. Q. Zhao, T.G. Wu, Y. Lin, B. Li, J.Y. Luo, and L.X. Wang Low-dose nesiritide improves renal function in heart failure patients following acute myocardial infarction Heart Vessels 25 2010 97 103
20. A.F. Randall CS, W.A. Paul, and D. Kenneth Clinical Outcomes at 180 days in the ASCEND-HF Trial: Double-Blind, Placebo-Controlled, Multicenter Acute Study of Clinical Effectiveness of Nesiritide in Subjects with Decompensated Heart Failure 15th Annual Scientific Meeting, Heart Failure Society of America 2011 971
21. F. Najafi, K. Jamrozik, and A.J. Dobson Understanding the 'epidemic of heart failure': a systematic review of trends in determinants of heart failure Eur J Heart Fail 11 2009 472 479